Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi Arabia
On Jun. 11, 2021, Moderna and Tabuk Pharmaceutical announced an agreement to commercialize the Moderna COVID-19 Vaccine and future variant-specific booster candidates in Saudi Arabia. Tabuk Pharmaceuticals will hold the marketing authorization for the Moderna COVID-19 vaccine in Saudi Arabia. Beyond the Moderna COVID-19 Vaccine and Modernaメs updated variant booster candidates.
Tags:
Source: Moderna
Credit: